Cargando…
Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
Vascular endothelial growth factor (VEGF) plays a crucial role in tumor angiogenesis. VEGF expression in metastatic renal cell carcinoma (mRCC) is mostly regulated by hypoxia, predominantly via the hypoxia-induced factor (HIF)/Von Hippel-Lindau (VHL) pathway. Advances in our knowledge of VEGF role i...
Autores principales: | Conti, Alessandro, Santoni, Matteo, Amantini, Consuelo, Burattini, Luciano, Berardi, Rossana, Santoni, Giorgio, Cascinu, Stefano, Muzzonigro, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777192/ https://www.ncbi.nlm.nih.gov/pubmed/24093097 http://dx.doi.org/10.1155/2013/419176 |
Ejemplares similares
-
Pathogenic and Diagnostic Potential of BLCA-1 and BLCA-4 Nuclear Proteins in Urothelial Cell Carcinoma of Human Bladder
por: Santoni, Matteo, et al.
Publicado: (2012) -
Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression
por: Liberati, Sonia, et al.
Publicado: (2014) -
Correction: Liberati, S., et al. Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression. Cells 2014, 3, 112–128
por: Liberati, Sonia, et al.
Publicado: (2014) -
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
por: Santoni, M, et al.
Publicado: (2013) -
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy
por: Giampieri, Riccardo, et al.
Publicado: (2019)